SWAlexander
Senior Member
- Messages
- 2,132
Hi everyone,
I wanted to share some exciting news with you all. Since the publication of the paper “Gene-editing in patient and humanized-mice primary muscle stem cells rescues dysferlin expression in dysferlin-deficient muscular dystrophy” in December 2024, I’ve been both thrilled and deeply engaged in further research. You can find the paper here: https://www.nature.com/articles/s41467-024-55086-0
After reading the study, I reached out to Prof. Dr. Spuler with several questions.
Developing a CRISPR therapy for muscular dystrophy
https://www.mdc-berlin.de/news/press/developing-crispr-therapy-muscular-dystrophy
She kindly responded with the following:
"Would you need another effort to reach a correct, maybe genetic, diagnosis? You are welcome to get an appointment in our Charité Outpatient Clinic. Please let me know how we can support you."
Since my primary physician was unfamiliar with the connection between a weak sarcolemma and the DYSF gene, I’ve been diving deeper into this topic to better explain the situation. Now, I’m in the process of finding a neurologist who either understands or is open to learning about the methylated DYSF gene. This referral is essential to be accepted into the research clinic to receive CRISPR therapy. It would mean the world to finally have muscles that could carry me more than 50 feet without pain. The possibility of this research making a real difference is incredibly motivating.
Dysferlin Protein: Key Roles, Genetic Locations https://swaresearch.blogspot.com/2025/01/dysferlin-protein-key-roles-locations.html
I wanted to share some exciting news with you all. Since the publication of the paper “Gene-editing in patient and humanized-mice primary muscle stem cells rescues dysferlin expression in dysferlin-deficient muscular dystrophy” in December 2024, I’ve been both thrilled and deeply engaged in further research. You can find the paper here: https://www.nature.com/articles/s41467-024-55086-0
After reading the study, I reached out to Prof. Dr. Spuler with several questions.
Developing a CRISPR therapy for muscular dystrophy
https://www.mdc-berlin.de/news/press/developing-crispr-therapy-muscular-dystrophy
She kindly responded with the following:
"Would you need another effort to reach a correct, maybe genetic, diagnosis? You are welcome to get an appointment in our Charité Outpatient Clinic. Please let me know how we can support you."
Since my primary physician was unfamiliar with the connection between a weak sarcolemma and the DYSF gene, I’ve been diving deeper into this topic to better explain the situation. Now, I’m in the process of finding a neurologist who either understands or is open to learning about the methylated DYSF gene. This referral is essential to be accepted into the research clinic to receive CRISPR therapy. It would mean the world to finally have muscles that could carry me more than 50 feet without pain. The possibility of this research making a real difference is incredibly motivating.
Dysferlin Protein: Key Roles, Genetic Locations https://swaresearch.blogspot.com/2025/01/dysferlin-protein-key-roles-locations.html